You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

sitravatinib

Showing 1 - 25 of 27
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Cervical Cancer Trial (Tislelizumab, Sitravatinib)

Not yet recruiting
  • Metastatic Cervical Cancer
  • (no location specified)
Jan 31, 2023

NSCLC, Lung Diseases, Lung Tumors Trial in New Haven (Sitravatinib, Pembrolizumab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +8 more
  • New Haven, Connecticut
    Yale University
Oct 26, 2022

Recurrent Endometrial Cancer, Solid Tumors Trial in Pittsburgh (pembrolizumab, Sitravatinib)

Recruiting
  • Recurrent Endometrial Cancer
  • Solid Tumors
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 12, 2022

Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +2 more
  • Nivolumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Carcinoma, Hepatocellular, Gastric/Gastroesophageal Junction Cancer Trial in China (Sitravatinib, Sitravatinib plus

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Gastric/Gastroesophageal Junction Cancer
  • Sitravatinib
  • +2 more
  • Hefei, Anhui, China
  • +17 more
Jul 28, 2022

Healthy Adults Trial in Madison (Sitravatinib, Pantoprazole, Famotidine)

Completed
  • Healthy Adults
  • Sitravatinib
  • +2 more
  • Madison, Wisconsin
    Covance Clinical Research Unit Inc.
Aug 24, 2022

Metastatic Breast Cancer Trial in Shanghai (Sitravatinib, Tislelizumab, Nab-paclitaxel)

Recruiting
  • Metastatic Breast Cancer
  • Sitravatinib
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer
Jul 31, 2022

Healthy Adults Trial in Dallas (sitravatinib)

Completed
  • Healthy Adults
  • sitravatinib
  • Dallas, Texas
    Covance Clinical Research Unit, Inc.
Apr 4, 2022

Lung Cancer, Small Cell Trial in Hangzhou (Tislelizumab, Sitravatinib)

Recruiting
  • Lung Cancer, Small Cell
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
May 13, 2022

Tumor Trial in Nedlands (Sitravatinib)

Completed
Has Results
  • Tumor
  • Sitravatinib
  • Nedlands, Western Australia, Australia
    Linear Clinical Research Pty Lt(LCR)
Nov 5, 2021

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in Houston (other,

Completed
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 30, 2022

Hepatic Impairment Trial in United States (sitravatinib)

Recruiting
  • Hepatic Impairment
  • sitravatinib
  • Tustin, California
  • +4 more
Apr 4, 2022

Advanced Solid Tumors Trial in Australia, China (Sitravatinib)

Completed
  • Advanced Solid Tumors
  • Sitravatinib
  • Blacktown, New South Wales, Australia
  • +16 more
Jan 10, 2023

Clear-Cell Renal Cell Carcinoma Trial in Houston (Sitravatinib, Nivolumab, Ipilimumab)

Enrolling by invitation
  • Clear-Cell Renal Cell Carcinoma
  • Sitravatinib
  • +2 more
  • Houston, Texas
    MD Anderson
Jan 23, 2022

Advanced or Metastatic Solid Malignancies Trial in United States (Sitravatinib, Nivolumab, Pembrolizumab)

Enrolling by invitation
  • Advanced or Metastatic Solid Malignancies
  • Sitravatinib
  • +4 more
  • Beverly Hills, California
  • +12 more
Aug 23, 2022

NSCLC Trial in Shanghai (Tislelizumab, Sitravatinib)

Recruiting
  • Non-small Cell Lung Cancer
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Dec 15, 2021

Melanoma Trial in Beijing (sitravatinib, tislelizumab)

Recruiting
  • Melanoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Nov 2, 2021

NSCLC Trial (BGB-A445, Docetaxel, Tislelizumab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • (no location specified)
Sep 6, 2023

Breast Cancer Stage IV, Triple Negative Breast Cancer, Breast Tumors Trial in Houston (Sitravatinib)

Recruiting
  • Breast Cancer Stage IV
  • +3 more
  • Sitravatinib
  • Houston, Texas
    Baylor College of Medicine
Jun 1, 2021

Clear Cell Renal Cell Carcinoma Trial in Houston (Sitravatinib, Nivolumab)

Active, not recruiting
Has Results
  • Clear Cell Renal Cell Carcinoma
  • Houston, Texas
    MD Anderson Cancer Center
Apr 27, 2021

Esophageal Squamous Cell Carcinoma Trial in China (Sitravatinib, Tislelizumab, Docetaxel)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Sitravatinib
  • +3 more
  • Hefei, Anhui, China
  • +29 more
Jul 28, 2022

Squamous Cell Carcinoma, Head And Neck, Squamous Cell Carcinoma Mouth, Squamous Cell Carcinoma of the Oral Cavity Trial in

Completed
  • Squamous Cell Carcinoma, Head And Neck
  • +2 more
  • Sitravatinib
  • Nivolumab
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Mar 30, 2021

Hepatocellular Carcinoma Trial in Worldwide (Sitravatinib, Tislelizumab, sitravatinib-matching )

Not yet recruiting
  • Hepatocellular Carcinoma
  • Sitravatinib
  • +3 more
  • Bengbu, Anhui, China
  • +81 more
Feb 1, 2023

Advanced Biliary Tract Cancer Trial in Seoul (Sitravatinib, Tislelizumab)

Unknown status
  • Advanced Biliary Tract Cancer
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jan 23, 2021

Urothelial Carcinoma, Urothelial Carcinoma Bladder, Urothelial Carcinoma Ureter Trial in United States (Sitravatinib, Nivolumab,

Recruiting
  • Urothelial Carcinoma
  • +4 more
  • Sitravatinib
  • +3 more
  • Tucson, Arizona
  • +33 more
May 21, 2021